A retrospective cohort of 401 patients with laboratory-confirmed COVID-19 admitted to Shenzhen Third People’s Hospital in China were included in this study. Viral RNA of SARS-CoV-2 was tested by quantitative reverse-transcription polymerase chain reaction in both the respiratory and rectal specimens. The results were further analyzed in combination with clinical data. Patients were divided into severe and nonsevere groups based on the disease severity defined according to China National Health Commission’s “Guidelines for Diagnosis and Treatment of SARS-CoV-2 Infection,” seventh version.
5 National Health Commission of China http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202003/W020200305456621460977.pdf Date accessed: May 8, 2020 Google Scholar
The study was approved by the Third People’s Hospital of Shenzhen Ethics Committee (2020-105). Further details are provided in the Supplementary Methods.